Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    20461379 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Capecitabine, Docetaxel and Gemcitabine in Patients With Advanced Pancreas Cancer
Condition: Pancreatic Cancer
Interventions: Drug: Capecitabine;   Drug: Docetaxel;   Drug: Gemcitabine

Indicates status has not been verified in more than two years